A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
MPSV4 and MCV4 can prevent four types of meningococcal disease, which make up about 70% of the cases in the U.S. The MenB vaccines prevent the Meningococcal B strain. MCV4 is preferred for people age 55 and younger.The recommendation for teens is one dose at age 11 and one dose at age 16.The doctor or nurse injects one dose into the muscle.eningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccine s protects against four types of meningococcal disease. An additional type of vaccine protects against serotype B, which also causes meningitis.